OBJECTIVE: To determine whether the temporal onset of visual phenomena distinguishes Lewy body disease (LBD) from Alzheimer's disease (AD), and to characterize the extent Lewy bodies and neurofibrillary tangles are associated with these clinical features. METHODS: Consecutive cases of autopsy-confirmed LBD (n = 41), AD (n = 70), and AD with amygdala-predominant Lewy bodies (AD-ALB) (n = 14) with a documented clinical history of dementia were included. We mailed questionnaires to next-of-kin asking about symptoms during life. Lewy pathology and neurofibrillary tangle pathology were assessed. RESULTS: The occurrence of visual hallucinations, misperceptions and family misidentification did not distinguish LBD from AD or AD-ALB, but the onset was earlier in LBD compared to AD and AD-ALB. When visual hallucinations developed within the first 5 years of dementia, the odds were 4-5 times greater for autopsy-confirmed LBD (or intermediate/high likelihood dementia with Lewy bodies) and not AD or AD-ALB. In LBD, limbic but not cortical Lewy body pathology was related to an earlier onset of visual hallucinations, while limbic and cortical Lewy body pathology were associated with visual misperceptions and misidentification. Cortical neurofibrillary tangle burden was associated with an earlier onset of misidentification and misperceptions in LBD and AD, but only with earlier visual hallucinations in AD/AD-ALB. CONCLUSION: When visual hallucinations occur within the first 5 years of the dementia, a diagnosis of LBD was more likely than AD. Visual hallucinations in LBD were associated with limbic Lewy body pathology. Visual misperceptions and misidentification delusions were related to cortical Lewy body and neurofibrillary tangle burden in LBD and AD/AD-ALB.
OBJECTIVE: To determine whether the temporal onset of visual phenomena distinguishes Lewy body disease (LBD) from Alzheimer's disease (AD), and to characterize the extent Lewy bodies and neurofibrillary tangles are associated with these clinical features. METHODS: Consecutive cases of autopsy-confirmed LBD (n = 41), AD (n = 70), and AD with amygdala-predominant Lewy bodies (AD-ALB) (n = 14) with a documented clinical history of dementia were included. We mailed questionnaires to next-of-kin asking about symptoms during life. Lewy pathology and neurofibrillary tangle pathology were assessed. RESULTS: The occurrence of visual hallucinations, misperceptions and family misidentification did not distinguish LBD from AD or AD-ALB, but the onset was earlier in LBD compared to AD and AD-ALB. When visual hallucinations developed within the first 5 years of dementia, the odds were 4-5 times greater for autopsy-confirmed LBD (or intermediate/high likelihood dementia with Lewy bodies) and not AD or AD-ALB. In LBD, limbic but not cortical Lewy body pathology was related to an earlier onset of visual hallucinations, while limbic and cortical Lewy body pathology were associated with visual misperceptions and misidentification. Cortical neurofibrillary tangle burden was associated with an earlier onset of misidentification and misperceptions in LBD and AD, but only with earlier visual hallucinations in AD/AD-ALB. CONCLUSION: When visual hallucinations occur within the first 5 years of the dementia, a diagnosis of LBD was more likely than AD. Visual hallucinations in LBD were associated with limbic Lewy body pathology. Visual misperceptions and misidentification delusions were related to cortical Lewy body and neurofibrillary tangle burden in LBD and AD/AD-ALB.
Authors: Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara Journal: Alzheimer Dis Assoc Disord Date: 2002 Oct-Dec Impact factor: 2.703
Authors: Hiroshige Fujishiro; Tanis J Ferman; Bradley F Boeve; Glenn E Smith; Neill R Graff-Radford; Ryan J Uitti; Zbigniew K Wszolek; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson Journal: J Neuropathol Exp Neurol Date: 2008-07 Impact factor: 3.685
Authors: A R Merdes; L A Hansen; D V Jeste; D Galasko; C R Hofstetter; G J Ho; L J Thal; J Corey-Bloom Journal: Neurology Date: 2003-05-27 Impact factor: 9.910
Authors: M E Kalaitzakis; L M Christian; L B Moran; M B Graeber; R K B Pearce; S M Gentleman Journal: Parkinsonism Relat Disord Date: 2008-07-07 Impact factor: 4.891
Authors: Debby Tsuang; Eric B Larson; Elizabeth Bolen; Mary Lou Thompson; Elaine Peskind; James Bowen; Wayne McCormick; Linda Teri; Walter Kukull; Darcy Vavrek; Thomas Montine; James B Leverenz Journal: Am J Geriatr Psychiatry Date: 2009-04 Impact factor: 4.105
Authors: Nobutaka Sakae; Keith A Josephs; Irene Litvan; Melissa E Murray; Ranjan Duara; Ryan J Uitti; Zbigniew K Wszolek; Jay van Gerpen; Neil R Graff-Radford; Dennis W Dickson Journal: Alzheimers Dement Date: 2019-08-06 Impact factor: 16.655
Authors: Georges Naasan; Suzanne M Shdo; Estrella Morenas Rodriguez; Salvatore Spina; Lea Grinberg; Lucia Lopez; Anna Karydas; William W Seeley; Bruce L Miller; Katherine P Rankin Journal: Brain Date: 2021-04-12 Impact factor: 15.255
Authors: Ahmad A Khundakar; Peter S Hanson; Daniel Erskine; Nichola Z Lax; Joseph Roscamp; Evangelia Karyka; Eliona Tsefou; Preeti Singh; Simon J Cockell; Andrew Gribben; Lynne Ramsay; Peter G Blain; Urs P Mosimann; Deborah J Lett; Matthias Elstner; Douglass M Turnbull; Charles C Xiang; Michael J Brownstein; John T O'Brien; John-Paul Taylor; Johannes Attems; Alan J Thomas; Ian G McKeith; Christopher M Morris Journal: Acta Neuropathol Commun Date: 2016-06-30 Impact factor: 7.801
Authors: Yuriko Katsumata; Erin L Abner; Shama Karanth; Merilee A Teylan; Charles N Mock; Matthew D Cykowski; Edward B Lee; Kevin L Boehme; Shubhabrata Mukherjee; John S K Kauwe; Richard J Kryscio; Frederick A Schmitt; David W Fardo; Peter T Nelson Journal: Acta Neuropathol Date: 2020-08-14 Impact factor: 17.088